Gold complexes have been explored as metallodrugs with great potential applications as
antitumoral agents. In particular, gold-phosphine derivatives seemed quite promising since …

Metal complexes have shown interesting preclinical and clinical results as antitumor drugs
and platinum compounds are well established in current cancer chemotherapy. However …

Nowadays, gold compounds occupy a relevant position constituting a promising class of
experimental anticancer metallodrugs. Several research efforts have been devoted to the …

Well known for their clinical anti-arthritic properties, gold-based drugs have also attracted
interest as potential antitumor agents with gold (I) phosphine derivatives being among the …

The title compound has been designed for antitumor activity based on structural features of
related known antitumor gold agents, that is, gold-monophosphine and gold-diphosphine …

The antineoplastic potential of a new stable mixed phosphine gold (I) complex containing
tris (tert-butyl) phosphine (tBu3P) and bis (diphenylphosphino) ethene (dppet), namely [Au …

Gold phosphine complexes, such as auranofin, have been recognized for decades as
antirheumatic agents. Clinical trials are now underway to validate their use in anticancer or …

The last decade has witnessed tremendous advances in the design of anticancer gold
complexes containing tertiary phosphines, a class of ligands that have significantly …

We report the application of cationic tri-and tetra-nuclear gold (I) phosphine complexes [Au 3
(μ-dppen) 3] X 3 and [Au 4 (μ-dppa) 4] X 4 (X= OTf, PF 6)[OTf= trifluoromethanesulfonate …

Gold (I) phosphine complexes exhibit promising properties for anticancer drug development.
Here we report on a series of gold (I) phosphine complexes containing a naphthalimide …